Glycaemic control after connected insulin pen initiation in people living with diabetes: results from a real-world setting
Adolfsson P, Guerci B, Hartvig NV, et al.
Diabetes Obes Metab. Pub. online 28 Aug 2025.
Leggi
Comparison of an energy-reduced mediterranean diet and physical activity versus an ad libitum mediterranean diet in the prevention of type 2 diabetes : a secondary analysis of a randomized controlled trial
Ruiz-Canela M, Corella D, Martínez-González MÁ, et al.
Ann Intern Med. Pub. online 26 Aug 2025.
Leggi
Dapagliflozin in patients hospitalized for heart failure: primary results of the DAPA ACT HF-TIMI 68 randomized clinical trial and meta-analysis of sodium-glucose cotransporter-2 inhibitors in patients hospitalized for heart failure
Berg DD, Patel SM, Haller PM, et al.
Circulation. Pub. online 29 Aug 2025.
Leggi
Risk differences and underlying factors of cardiovascular events and mortality in patients with type 2 diabetes versus type 1 diabetes: a longitudinal cohort study of Swedish nationwide register data
Patsoukaki V, Lind L, Lampa E, et al.
Lancet Diabetes Endocrinol. 2025:S2213-8587(25)00165-2.
Leggi
Biomarkers for cardiovascular-kidney metabolic syndrome: clinical utility in diagnosis, screening, and treatment
Yau K, Cherney DZI, Odutayo A
Diabetes Obes Metab. Pub. online 26 Aug 2025.
Leggi
Cardiovascular and kidney outcomes of GLP-1 receptor agonists in adults with obesity: a target trial emulation study
Tang H, Lu Y, Zhang B, et al.
Diabetes Obes Metab. Pub. online 28 Aug 2025.
Leggi
FDA accepts proposal for reasonably likely surrogate endpoint for ‘MASH’ all-cause mortality or liver-related events
27 agosto 2025
Leggi
2025 ESC Clinical Consensus Statement on mental health and cardiovascular disease: developed under the auspices of the ESC Clinical Practice Guidelines Committee
Bueno H, Deaton C, Farrero M, et al.
Eur Heart J. Pub. online 29 Aug 2025.
Leggi